Stocks Cerner Corp

More

  • It's the basic question when investing in a stock: is it on the way up or down? The street has developed numerous ways of attempting to predict what will happen, estimating various attributes tied to stock performance in order to determine what the future holds for a company's valuation. After dissecting the data, analysts following a particular stock produce a price target of where they believe the stock is headed. With data from Thomson Reuters, CNBC.com grouped stocks in the S&P 500 with aver

    It's the basic question when investing in a stock: is it on the way up or will it go down? Wall Street has developed numerous ways of attempting to predict what will happen.

  • The “Mad Money” host admits he made a mistake, and now recommends a different name in the health care information technology wars.

  • Cramer's Case to Sell Allscripts

    Mad Money's Cramer explains why the best way to play the expansion of electronic medical records is to sell Allscripts and swap into Cerner, the next time the stock gets pulled down with the rest of the market.

  • NYSE Trader

    Technology stocks have been gaining momentum in 2012, up eight of the last nine weeks.  However, over the last 12 months, consumer discretionary and health care companies have really powered the rally.

  • By The Numbers | Stocks on the Move Now

    Caesars Entertainment is among several companies showing unusual movement in Wednesday's trading session.

  • NYSE_traders_busy3_200.jpg

    When it comes to combating financial markets that all seem to move in unison, the options are getting so limited that some are questioning whether stock picking is a dying art.

  • Cost of healthcare

    Expected government cuts to Medicare and Medicaid, the uncertainty of health care reform and looming patent expirations are weighing heavily on the outlook of the biggest companies in the sector: large-cap pharmaceutical stocks.

  • The "Mad Money" host also talks Cerner, Allscripts and Wabco

  • We ran out of time on TV, but we didn't forget. Click here for our Fast Money Final Trades.

  • With the bull market in its second year and with volatility picking up, the "Fast" traders said it's time to turn away from buying blind and switch into stock-picker mode.

  • Six in 60

    Here's why you should keep a close eye on these six stocks.

  • See what's happening, who's talking and what will be making headlines on Wednesday's Squawk on the Street.

  • Six in 60

    Here's why you should keep a close eye on these six stocks.

  • Just when you thought it was safe to go into the water – new signs are emerging that turmoil may lurk just below the surface.

  • What follows is a look at stocks in the S&P 500 displaying unusual volume in today's trading session.

  • Gold rose to session highs near $1,260 an ounce on Tuesday. Is this a good time for investors to get into the commodity? Patrick Cunningham, managing director at Manning & Napier discussed his best plays.

  • memcorr.jpg

    The correlation of S&P 500 members to daily move in the benchmark overall has been steadily rising toward parity over the last 10 years, a sign that exchange-traded funds, electronic trading and a short-term mentality is slowly killing individual stock picking based on fundamentals.

  • The Lightning Round is extended in this CNBC.com exclusive feature.

  • As investors brace for what could be another roller coaster ride for the stock market this summer, CNBC.com conducted a stock screen of the S&P 500 index, searching for the top ten percentage gainers in the past ten years.

  • With the government expected to spend $19 billion upgrading medical records, is Allscripts a can’t lose trade? Hear from the CEO!